Brad Bourne is the Director of Field Reimbursement, Oncology at AstraZeneca. He is responsible for leading a team of 8 Oncology Field Reimbursement Managers covering the southern United States. The AstraZeneca Oncology FRM team has successfully supported the launch of multiple oncology products including Imfinzi, Tagrisso, Lynparza, Calquence, and Lumoxiti. In his 14 years with AstraZeneca, Mr. Bourne has held various positions in Sales and Market Access supporting specialty biologics and oncology products. Prior to joining AstraZeneca in 2005, he began his 19 year pharmaceutical career with Schering-Plough supporting brands across multiple therapeutic areas.